Labor doubles down on domestic manufacturing The prime minister has made claims Australia must be more self-reliant. The Canberra Times · Aug 15, 2022
Australian virus cases close to 10 million The total number of COVID-19 cases identified in Australia since the start of the pandemic is closing in on 10 million. AAP · Aug 15, 2022
Moderna vaccine: how the new Covid bivalent Omicron jab works An Omicron-specific booster vaccination has been approved in the UK Evening Standard · Aug 15, 2022
Is Moderna Preparing To Soar 20% And Tackle This Big Level? What To Watch On The Weekly Chart Moderna, Inc (NASDAQ: MRNA) spiked up almost 5% off Friday’s closing price at one point on Monday, before hitting a resistance level at the $179 level and running into a group of sellers. Benzinga · Aug 15, 2022
First Covid-19 jab to target two strains included in autumn booster programme Adults over 50 and clinically vulnerable people will be offered the first Covid-19 jab to target two strains of the virus, as part of the UK’s autumn booster programme. Evening Standard · Aug 15, 2022
‘Next generation’ Covid booster jab to be offered to adults over 50 from autumn Health Secretary Steve Barclay has said the vaccine will be part of the autumn booster programme. The Independent UK · Aug 15, 2022
Who can get a Covid vaccine booster in the UK? The autumn booster program for Covid vaccinations will begin shortly. Over 50s, carers, frontline health workers and those at clinical risk will be inited to get a booster jab. Edinburgh Live · Aug 15, 2022
Looking At Moderna's Recent Whale Trades Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Benzinga · Aug 15, 2022
Covid: New dual-strain booster vaccine targeting Omicron to be rolled out in autumn UK first country to approve use of so-called bivalent vaccine as officials prepare for winter and expected rise in Covid cases The Independent UK · Aug 15, 2022
Dual-variant Covid vaccine approved for UK booster programme Moderna jab designed to target original variant and Omicron has been given go-ahead by UK regulator The Guardian - UK · Aug 15, 2022
UK takes world’s first step toward omicron-tailored shot The U.K. has granted the world’s first approval for a COVID-19 vaccine targeting a variant in a bid to sharpen its response to an evolving coronavirus. Tribune News Service · Aug 15, 2022
New covid jag approved by UK to specifically target Omicron will be fourth vaccine Moderna’s chief medical officer, Dr Paul Burton, previously said that the new jag can boost a person’s antibodies to such high levels that it may only be needed once per year. Daily Record · Aug 15, 2022
British regulator 1st to OK Moderna's updated COVID booster British drug regulators have become the first in the world to authorize an updated version of Moderna’s coronavirus vaccine that aims to protect against the original virus and the omicron variant The Independent UK · Aug 15, 2022
New Moderna vaccine to target two Covid strains in one dose The UK has become the first country to approve the new booster, which is said will help protect people from Covid over the winter Manchester Evening News · Aug 15, 2022
The Times of India · Aug 15, 2022 Coronavirus: UK approves Moderna vaccine targeting Omicron variant, key points to know The UK's Medicine and Healthcare products Regulatory Agency (MHRA) has approved an updated Moderna vaccine against the coronavirus' Omicron variant.
The National (Scotland) · Aug 15, 2022 'Next generation' Covid jab approved in UK for use in adults A new coronavirus booster jab has been approved for use in adults.
The Independent UK · Aug 15, 2022 New Omicron-specific vaccine from Moderna approved by UK regulator New vaccine is a ‘sharpened tool in our armoury’ to fight against Covid, says Dr June Raine, chief for the UK medicines regulator
Daily Mirror · Aug 15, 2022 UK becomes first country to approve new Covid jab specifically targeting Omicron Moderna's chief medical officer, Dr Paul Burton, previously said that the new jab can boost a person's antibodies to such high levels that it may only be needed annually
Evening Standard · Aug 15, 2022 First Covid vaccine that targets two variants approved in UK The ‘next generation’ Moderna jab may only need to be administered once a year
The Guardian - UK · Aug 15, 2022 Covid vaccine designed to target two variants approved for use in UK JCVI will decide whether to use Moderna-manufactured jab in planned autumn booster campaign
Wales Online · Aug 15, 2022 Once-a-year Covid jab approved for use in adults in UK The new Moderna vaccine could put an end to three or four injections a year - and fights Omicron
The Independent UK · Aug 15, 2022 ‘Next generation’ Moderna coronavirus booster jab approved for use in UK adults The jab is the first to target two strains of Covid-19.
Asharq Al-Awsat · Aug 15, 2022 Southern Hemisphere to Get First mRNA Vaccine Facility Covid-19 vaccine maker Moderna announced Monday that it will open an mRNA vaccine manufacturing facility in the Australian city of Melbourne, a first for the southern hemisphere. The project will be based at one of Australia's largest universities, Monash, and will produce 100 million vaccine doses a year for Covid-19,…
Benzinga · Aug 8, 2022 Moderna Whale Trades Spotted A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 14 strange trades.
Benzinga · Aug 5, 2022 Looking At Moderna's Recent Whale Trades Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.